Advertisement

Reactions Weekly

, Volume 1731, Issue 1, pp 90–90 | Cite as

Dalbavancin

Nausea, vomiting and increased creatinine levels during off-label use: 2 case report
Case report
  • 12 Downloads

Reference

  1. Tobudic S, et al. Dalbavancin as primary and sequential treatment for gram-positive infective endocarditis: 2-year experience at the general hospital of vienna. Clinical Infectious Diseases 67: 795-798, No. 5, 1 Sep 2018. Available from: URL: http://doi.org/10.1093/cid/ciy279 - Austria

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations